Before COVID-19, the healthcare industry lagged behind the rest of the world in tech adoption. This all changed with the pandemic, as hospitals quickly adopted virtual diagnostic and telemedicine apps to deal with the crisis. One of the innovations that cropped up was the introduction of the AI chatbot for healthcare companies. A health chatbot can truly revolutionize the way we approach medicine and patient care (here at the link, you can find a complete guide by Topflight Apps). Let’s take a quick look at the history and future of chatbots in the healthcare industry.

What is an AI chatbot for Healthcare?

Healthcare chatbots run on the rules of machine learning and artificial intelligence. A medical chatbot app can interact with patients and carry out repetitive tasks like sending emails, resulting in analysis, answering questions, or providing solutions to patients.

The use of chatbot technology in healthcare really originated during the COVID-19 pandemic. Doctors, nurses, and administrative staff were under considerable strain and didn’t have time to complete the many simple and monotonous tasks that were taking up their time. Chatbots have worked in the retail industry and customer service sectors for years, reducing the number of time workers spend performing monotonous tasks. By deploying them in the healthcare sector, healthcare staff could leave the simple and repetitive work to the bots and focus on the more critical and complex work they needed to do.

Patients don’t need to wait in line for hours to have their queries answered or appointments booked – chatbots can do that. It provides more experience for patients than ever before.

The Benefits of Chatbots

Using an artificial intelligence healthcare chatbot system has benefits for doctors and patients alike:

• Availability: Hiring staff to man the phones around the clock isn’t feasible. Not all calls will be emergencies, either. A chatbot is available at all times to answer any query you may have.
• Critical information: Chatbots can provide information instantly when every second counts, including collecting information about previous records, allergies, and more.
• Building rapport with customers: Chatbots can exchange pleasantries, offer a warm greeting, and steer customers through a self-help website. They can also escalate queries that are more urgent.

What can chatbots do for your hospital?

Chatbots can carry out a number of functions in your business, depending on your needs. Here are just a few:

1. Scheduling appointments

Patients can book appointments at any time directly from the chatbot. The bots can assign a doctor to a patient, send emails with patient information or completed questionnaires, and book a slot in the doctor’s calendar and the patient’s calendar. This will reduce stress and effort on everyone’s part.

2. Checking for symptoms

Patients can check symptoms on a healthcare chatbot to measure the severity of the situation. The chatbot will remember the patient’s details, so they don’t need to keep entering information every time.

3. Providing support and information

Some patients keep calling with the same set of basic questions, so having an infinitely patient and well-informed chatbot to answer queries can be valuable. They have the responsibility of managing additional queries and reducing calls. Chatbots are also helpful to healthcare providers who need to access patient information quickly.

4. Claims and coverage checks

Patients can check their existing coverage and file for claims through their chatbot, which has all of their information ready. This will also make it easier for doctors and payers to pre-authorize billing payments and other requests.

5. Providing a better patient experience

Doctors can’t always pick up the phone when we need them to, but a chatbot can cover as many patient queries as you need them to and virtually never go offline. They can manage the tasks previously left up to humans, including booking appointments, and never go on vacation or have a bad day.

6. Mental health assistance

There have been some experiments with chatbots in therapy. Bots can offer a sympathetic ear or raise the alarm concerning mental health scenarios. While they can’t provide counseling, they can point people in distress toward the resources they need.

Now you know all of the uses of an AI chatbot for healthcare, wouldn’t you like to use one of your own? Reach out if you would like more information about creating a smart chatbot for your business (find out the explicit details in this article).

In the Global Tuberculosis Report 2022, new data from the World Health Organization revealed that TB incidence increased in 2021 for the first time in nearly two decades and that fatalities subsequently rose too. The Stop TB Partnership expressed alarm over an increasingly terrible scenario and the effects it will have on individuals, health care systems, and economies as a result of this, which includes 4,400 people dying every day.

The Stop TB Partnership exhorts the global community to recognise the threat to public health posed by an airborne illness with drug-resistant strains that is increasing in mortality and frequency and to act right away by making the critical financial investments required to fight TB.

The number of new cases of TB per 100,000 people per year increased by 3.6% between 2020 and 2021, reversing annual decreases of roughly 2% for most of the previous two decades.

Throughout 2019 and 2021, the expected number of TB deaths climbed globally, reversing a 14-year reduction that occurred between 2005 and 2019. 1.6 million people died from TB in 2021, including 187, 000 HIV-positive individuals. From 2018 to 2021, 26.3 million patients received TB treatment. The 40 million targets for the period of 2018–2022, set at the UN High-Level Meeting on TB in 2018, are a far cry from the current figure.

It has become very evident that people now have a very serious scenario on their hands with an airborne illness that is entirely disregarded, and which has been permitted to run uncontrolled over the past two years, said the executive director of the Stop TB Partnership, Dr. Lucica Ditiu. A higher risk of death has resulted from increased transmission and longer periods during which infections were undetected and untreated, which allowed tuberculosis to dwell and progress into more severe forms of the illness.

Every single person should be outraged and insist that their authorities and decision-makers take action right away because everyone is now at risk, she continued, and the World Health Organization study states this in black and white.

According to the most recent data in the report, TB is expected to overtake COVID-19 as the most lethal infectious disease worldwide. In actuality, this avoidable, treatable, and curable disease claims the lives of 4,400 people daily, or three people every minute.

The report did include some positive information. During the epidemic, TB treatment success rates remained stable, especially in Africa.

A new type of COVID-19 vaccination that is provided via inhalation rather than injection was this week introduced in Shanghai, the commercial city of China, in what is thought to be a first for the world.

In September, Chinese authorities gave the CanSino Biologics vaccination the go-ahead to be used as a booster. The vaccine is currently being administered to the first patients; it is taken by mouth from a container that resembles a take-out coffee cup and has a short mouthpiece.

According to chief medical officer at Shanghai United Family Hospital Pudong, Dr. Zhao Hui, the body’s first line of defence is the mucous membrane of the respiratory system. They want that to be immediately stimulated to increase immunity, and using the inhaled vaccine does that. The new vaccination, which will be administered alongside standard injection doses, is being given by several hospitals.

The chief medical officer at St. Vincent’s Health Australia, Erwin Loh, commented on what he claimed was the first application of the technology. He said the development of inhaled vaccines is significant not only because they have the potential to prevent infection but also because they may reduce vaccine hesitancy.

A sizable minority of people refuse to get the immunisation because they are afraid of needles. Despite the fact that they might not express it, he added. For China, which continues to be a global outlier due to its adherence to its zero-COVID policy, which aims to eradicate community occurrences of the virus, increasing vaccination uptake is essential. There are still targeted lockdowns in place in Shanghai, which has reported 11 local asymptomatic cases and no new locally acquired symptomatic coronavirus cases as of October 27.

In announcing the inhalable vaccine launch this week, the Shanghai government’s WeChat account stated that 23 million of the city’s 26 million inhabitants had received their initial COVID vaccinations in full and that more than 12 million had obtained booster shots.

Over 90% of the population in China has had a vaccination, according to official figures from the Chinese government. The nation has depended on inactivated vaccines that are made domestically; no mRNA vaccines have been imported or introduced as of yet. An inactive shot is available as an aerosol with the inhaled vaccination.

Loh is optimistic that the outcomes of Shanghai’s experiment with inhaled vaccines will persuade other nations to do the same. He believes the future will be inhaled vaccines for respiratory illnesses like COVID-19.

The White House issued a warning this week that HIV patients, kidney transplant recipients, and other immunocompromised people are particularly susceptible to COVID this winter because emerging omicron subvariants are impervious to important antibody therapy.

Some of the key methods they have used to safeguard immunocompromised people like Evusheld may no longer be effective in the future due to a number of new subvariants that are appearing. The White House COVID task force’s leader, Dr. Ashish Jha, warned reporters on October 25th that this presents a significant difficulty.

President Joe Biden warned the estimated 7 million adults in the United States with weakened immune systems that they were particularly at risk. However, he was only able to advise them to speak with their doctor about the appropriate safety measures.

The president warned about new varieties before receiving his booster shot on October 25th, saying that some existing defences may become useless for the immunocompromised. Unfortunately, this implies one might be particularly at risk this winter. He urged me to speak with the doctors about the best defences to take and to be extra cautious.

The message runs counter to previous statements from the White House that the United States has all the necessary medications and vaccines to combat COVID this winter, when health authorities anticipate another uptick. This might be the case for the general populace, but not for those with weakened immune systems. They consist of folks who have cancer, have undergone organ transplants, are HIV positive, and are receiving medication for autoimmune illnesses.

The Food and Drug Administration has approved the antibody cocktail Evusheld to prevent COVID in people aged 12 and older who have slightly or severely weakened immune systems. Prior to infection, the medication is given as two injections once every six months.

AstraZeneca’s Evusheld has helped close a protection gap for people with weakened immune systems who are unable to produce a robust immune reaction to vaccines. As per an infectious disease specialist, Camille Kotton, who specialises in treating people with weakened immune systems, the medication, along with numerous rounds of immunisation, had caused considerable declines in hospitalisation within this cohort over the previous few months.

According to Kotton, a medical professional at Massachusetts General Hospital and a member of the independent vaccine advisory committee for the Centers for Disease Control and Prevention, they have been in a sweet spot for perhaps several months now in terms of immunocompromised patients having decent protection and then good treatment options.

The National Institutes of Health state that more immunological evasive omicron subvariants, such as BA.4.6, BA.2.75.2, BF.7, BQ.1 as well as BQ.1.1, are resistant to Evusheld. For instance, Columbia University researchers discovered that Evusheld was no longer effective against BA.4.6.

Additionally, the NIH reports that BQ.1 and BQ.1.1 are probably immune to bebtelovimab, the monoclonal antibody created by Eli Lily to stop people with weakened immune systems who contract COVID from developing severe disease. That makes those with weakened immune systems more susceptible as these subvariants circulate more widely in the U.S. According to CDC data, this swarm of more recent subvariants combined accounts for around 38% of cases in the U.S. as omicron BA.5 falls.

Despite the fact that Pfizer’s antiviral Paxlovid is still active against the omicron subvariants, Kotton explained that people who have had organ transplants frequently are unable to take the medication due to the way it interacts with other medications they require.

Kotton remarked that she is worried that immunocompromised patients will face difficulties in the near future. Evusheld’s monoclonal antibodies will offer reduced protection, and bebtelovimab will offer inadequate treatment for a number of the developing types.

Furthermore, no assistance is currently on the way. The monoclonal antibodies that the subvariants are eroding are not yet being replaced, according to Kotton. As COVID develops, Jha admitted at the White House on October 20^th that the United States has fewer therapy and prevention choices for those with weakened immune systems. He said that Republican resistance prevented Congress from passing $22.5 billion in financing for the country’s COVID response.

In response to a question from a reporter, Jha said, they had thought that over time, as the outbreak went along, as their war against this virus went forward with it, they would be able to grow their medicine cabinet. That medicine cupboard has really diminished because of the lack of funds from Congress, and that does put disadvantaged individuals at risk.

The most urgent problem with the pandemic right now, according to a virologist at Johns Hopkins University named Andrew Pekosz, is how to protect those with weakened immune systems.

Getting novel antibody therapies out of the lab and into clinics is what they need to focus on, according to Pekosz. In the lab, scientists are familiar with the appearance of next-generation monoclonal antibodies.

Kotton advised those with weakened immune systems to keep up with their vaccinations, which includes receiving the new booster that specifically targets omicron BA.5. Six doses have already been administered to those who have stayed current throughout the pandemic. According to CDC recommendations, those who are starting from scratch should have a three-dose main series of Moderna or Pfizer with the older generation shots followed by a new booster that targets omicron.

According to Kotton, the immune-resistant omicron subvariants could become more prevalent this winter as people congregate for the holidays, so those with weakened immune systems should continue to use caution. However, she pointed out that compared to the general public, this group has been more rigorous about wearing masks and using preventative steps to avoid the illness.

The main issue, according to Kotton, is that most people have moved on and are no longer adopting simple precautions, like wearing masks, that may stop infections and protect the weak. She said if everyone masked more in public places, it would improve security for them and enable them to have a higher probability of returning to various activities in a safer manner.

On October 20^th, NBC News questioned Jha about whether Biden’s advice to those with weakened immune systems to consult their doctors about safeguards represented a shift in the onus of duty from the larger community to the individual. They care about all Americans, but primarily the most vulnerable Americans, as a society, said Jha. Therefore, he believed that it was all of their responsibility to take care of our fellow Americans who have impaired immune systems.

Before meeting indoors with someone who is at a high risk of becoming ill, the CDC advises residents of communities where the Covid risk level is medium to self-test and put on a high-quality mask. High-risk individuals should use a high-quality mask when in public.

According to the CDC, when the COVID level is high, everyone should think about wearing good-quality masks, and the vulnerable should think about limiting indoor activities in public that aren’t necessary.

A hospital management information system- HMIS created by the Indian government, is about to be adopted by the All India Institute of Medical Science in New Delhi.

The National Informatics Centre, the IT systems agency inside the Ministry of Electronics and Information Technology, built the e-hospital HMIS, and the predecessor AIIMS institute will begin deploying all of its components at the beginning of next year.

The deployment is a part of the hospital’s move toward being paperless.

This announcement follows a NIC team’s last week’s hospital demonstration of the e-hospital modules. The patient registration, admission, discharge, and transfers, invoicing, clinics, LIS, RIS, pharmacy, OT management, dietary, and laundry modules are the current 10 modules of this cloud-based platform.

A working group and an oversight monitoring committee will be established for this implementation.

The MeghRaj national cloud system of the NIC hosts the HMIS that drives the e-hospital platform. It acts as a one-stop solution that links patients, hospitals, and doctors on a single digital platform and facilitates the digitization of internal processes and workflows of hospitals. It was created with the ultimate goal of enhancing the provision of healthcare services throughout India.

The e-hospital platform has recently been adopted by about 1,093 hospitals in India, including AIIMS Raipur.

To link all of its public hospitals under a single digital platform, the Delhi government is working to establish a HIMS that covers the entire region. It is anticipated that the system, which is being developed by NEC Corporation India, will be implemented this year.